Company Filing History:
Years Active: 2000
Title: Naoko Kato: Innovator in Blood Coagulation Factor XIII
Introduction
Naoko Kato is a prominent inventor based in Saitama, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of blood coagulation factors. Her innovative work has led to advancements in medical treatments and therapies.
Latest Patents
Naoko Kato holds a patent for "Stabilized aqueous liquid preparations of blood coagulation factor XIII." This patent describes a stabilized aqueous liquid preparation of human blood coagulation factor XIII, which is prepared using recombinant DNA technology. The formulation includes components such as galactose, sucrose, sorbitol, glutamate, aspartate, and histidine. Notably, this preparation maintains its biological activity even after prolonged storage.
Career Highlights
Throughout her career, Naoko Kato has worked with various organizations, including Centeon Pharma GmbH. Her expertise in biotechnology and her innovative spirit have positioned her as a key figure in her field.
Collaborations
Naoko has collaborated with notable individuals, including Shuji Kondo. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Naoko Kato's contributions to the field of blood coagulation factors exemplify her dedication to innovation and medical advancement. Her work continues to impact the biotechnology industry positively.